Filing Details
- Accession Number:
- 0000899243-19-022005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-19 08:35:30
- Reporting Period:
- 2019-08-16
- Accepted Time:
- 2019-08-19 08:35:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1466301 | Clovis Oncology Inc. | CLVS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1266569 | J Patrick Mahaffy | C/O Clovis Oncology, Inc. 5500 Flatiron Parkway, Suite 100 Boulder CO 80301 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-08-16 | 400 | $5.56 | 919,187 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-16 | 400 | $5.58 | 919,587 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-16 | 3,706 | $5.57 | 923,293 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-16 | 2,100 | $5.61 | 925,393 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-16 | 6,400 | $5.61 | 931,793 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-16 | 11,314 | $5.58 | 943,107 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-16 | 3,700 | $5.59 | 946,807 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-16 | 11,053 | $5.59 | 957,860 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-16 | 5,100 | $5.60 | 962,960 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-08-16 | 5,827 | $5.60 | 968,787 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,000 | Indirect | By son |
| Common Stock | 1,000 | Indirect | By daughter |
Footnotes
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Billionaire Hedge Funds
